Pharma

Your Article Summary

See Latest Articles

Biologics dont need long market exclusivity, FTC says
American Medical News , 06/30/09

Trapp D - A recent Federal Trade Commission report asserting that original biopharmaceutical drug manufacturers do not need lengthy exclusive marketing periods to maintain innovation has not driven supporters from a bill that would extend such protection.

Today in Biotechnology...keeping you current

Receive free subspecialty "5-minute updates" via email

Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Abbott, 11/16/09

Position statement of the Portuguese Society of Nephrology on the clinical use of biotechnological drugs in renal patients
Portuguese Journal of Nephrology and Hypertension, 10/12/09

Orally Disintegrating Tablets: The Effect of Recent FDA Guidance on ODT Technologies and Applications
Pharmaceutical Technology, 10/14/09

See All of Biotechnology